RO6799477
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO6799477, covering 2016-11-02 to 2017-06-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477 [Phase 1]